Mehrnoosh Tashakori, MD PhD
@TashakoriM
Followers
3K
Following
23K
Media
121
Statuses
8K
Hematopathologist at the University of Minnesota 🔬🩸🧬 #leusm #lymsm #mmsm #genetics #p53
Minneapolis, MN
Joined March 2017
Excited to see our work online🤩 pleased to had the chance to leverage my knowledge in #p53 in this work & honored to work with @JoeKhouryMD, our impeccable leader in this study, and amazing collaborative forces from #leukemia & #hemepath team, statisticians,& many more. a🧵
17
45
197
RT @LFSAssociation: It is with deep sorrow and profound respect that we honor the memory of Dr. Pierre Hainaut, a cherished member of the L….
0
2
0
Turn old photos into videos and see friends and family come to life. Try Grok Imagine, free for a limited time.
10
22
140
RT @sindhucherian: Did you know… Not all CD38 directed targeted therapy has the same impact on flow cytometry studies. To learn more, see t….
0
17
0
RT @DrHKantarjian: Actively recruiting in @MDAndersonNews #Leukemia: Rezatapopt +/- azacitidine combination with R/R MDS/AML with TP53-Y220….
0
8
0
RT @sindhucherian: About to start your Hemepath rotation? This video is for you! Visit the ICCS YouTube channel and website for more educ….
0
9
0
✨Don’t miss the chance to learn about flow cytometry from the fabulous @sindhucherian 😊.#hemepath #FlowEdu.
Our latest video is out and this time it's back to basics! .@sindhucherian's video "What is flow cytometry?" gets you started! This video is available for free but for more, sign up for ICCS membership: Check out the video here! 👇.
0
4
16
🚨 New paper! 🚨 myeloid neoplasms w/ a data-driven twist! 📊 Our latest in @BCD_AACR addresses classification gaps in the 🌎 of myeloid neoplasms 🧵 .led by @CLachowiez in collaboration w/@PapaemmanuilLab @Elsa2Bernard & a huge team of amazing friends
0
0
3
RT @sanamloghavi: 🧬 O-CMML (oligomonocytic) classification needs some 🧬 #TLC! We need to incorporate CMML type gene signatures for O-CMML….
0
1
0
💥 NPM1-mutated AML: Blast count? Meh.🫤 irrelevant .NPM1 mutations define AML regardless of blasts (5% WHO and 10% ICC cutoffs both irrelevant) .Same survival, same genetics—time to treat these as one entity! 💪#LeuSM 4/
0
0
3
RT @jake_bledsoe: Our study on "ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillan….
0
17
0
RT @ICCS_Education: Register now for the 2025 ICCS Virtual Course to be held August 21 and 28! The topic is "Validation Boot Camp and Qual….
0
7
0
FIVE Fascinating Facts About Auer Rods.Auer rods are more than just pink needles in blasts. A thread…🧵
1
0
4
RT @AdamMGrant: The most enduring marker of success isn't wealth, fame, or power. It’s what we create and contribute to others. In the sho….
0
612
0
RT @sanamloghavi: Our @MDAndersonNews experience .Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor….
pubmed.ncbi.nlm.nih.gov
Our study provides data-driven technical insights for laboratories considering MFC AML MRD implementation and offers strong evidence supporting the utility of MRD assessment by MFC in patients with...
0
11
0
RT @ICCS_Education: Don't miss our upcoming webinar on Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms/Proliferations, on….
0
8
0
RT @AmeetRKini: ICCS has revitalized their YouTube channel and will be releasing a range of #flowcytometry videos for all levels, from begi….
0
39
0
RT @ICCS_Education: 🚀 New Video Alert! Don't Miss It! 🚀.The ICCS Outreach Committee has released a new video focusing on the use of tandem….
0
10
0
RT @SamreenfatimaMD: Happy hemepath fellowship Match Day! We’re excited to announce our new incoming fellows! Welcome to the UMN Hemepath f….
0
3
0
RT @ICCS_Education: Check out the latest module from the ICCS Q&S committee on automated sample preparation systems for clinical flow cytom….
0
9
0
RT @theNASciences: Congratulations Sharon Dent of @MDAndersonNews, newly inducted #NASmember! #NAS162 #cancerresearch .
0
7
0